Drawing for INPHARMATICA

USPTO serial 75625589

INPHARMATICA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
SLOAN, CYNTHIA
Law office
TMO LAW OFFICE 116 - DOCKET CLERK

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INPHARMATICA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

J.Allison Strickland

J ALLISON STRICKLAND FROSS ZELNICK LEHRMAN & ZISSU, PC866 UNITED NATIONS PLZNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009COMPUTER HARDWARE; SOFTWARE FOR ACCESSING, PROCESSING, STORAGE, RETRIEVAL AND PRESENTATION OF BIOLOGICAL, CHEMICAL AND CLINICAL DATA AND ASSOCIATED COMMERCIAL INFORMATION; SOFTWARE FOR USE IN BIOLOGICAL AND CHEMICAL MODELLING, ANALYSIS AND INFORMATION MANAGEMENT; SOFTWARE FOR COMPUTER-AIDED MOLECULAR DESIGN; SOFTWARE FOR USE IN DRUG DISCOVERY INFORMATION SYSTEMS; PRE-PROCESSED BIOLOGICAL DATA CONTAINED IN SOFTWARE OR DATABASES; PRE-PROGRAMMED TAPES, CASSETTES, COMPUTER DISCS AND CD ROMSACTIVE—
042DESIGN, UPDATING, MAINTENANCE AND RENTAL OF COMPUTER SOFTWARE, HARDWARE, SYSTEMS AND DATABASES; ANALYSIS OF DATABASES; COMPUTER CONSULTATION; PROVIDING DATABASES AND PROVIDING ACCESS AND LEASING TIME TO DATABASES CONTAINING INFORMATION RELATING TO BIOLOGY, GENOMICS, PRETEOMICS, CHEMISTRY, BIOTECHNOLOGY, PHARMACEUTICALS, DRUG DISCOVERY AND DRUG DEVELOPMENT; BIOTECHNOLOGY AND PHARMACEUTICAL RESEARCH; PROFESSIONAL CONSULTATION IN THE FIELDS OF BIOTECHNOLOGY AND DRUG DEVELOPMENT; TECHNICAL PROJECT STUDIES RELATING TO BIOLOGY, GENOMICS PROTEOMICS, CHEMISTRY, BIOTECHNOLOGY, PHARMACEUTICALS, DRUG DISCOVERY AND DRUG DEVELOPMENT; CONDUCTING SCIENTIFIC RESEARCH AND DEVELOPMENT OF PRODUCTS, TREATMENTS AND SERVICES FOR OTHERS; ANALYSIS AND PREPARATION OF DATA RELATING TO BIOLOGY, GEONOMICS, PROTEOMICS, CHEMISTRY, BIOTECHNOLOGY, PHARMACEUTICALS, DRUG DISCOVERY AND DRUG DEVELOPMENT FOR SCIENTIFIC RESEARCH; PROVISION OF INFORMATION RELATING TO BIOLOGY, GEOMICS, PROTEOMICS, CHEMISTRY, BIOTECHNOLOGY, PHARMACEUTICALS, DRUG DISCOVERY AND DRUG DEVELOPMENTACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 27, 2005MAB1ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT—
Apr 27, 2005ABN1ABANDONMENT - EXPRESS MAILED—
Apr 27, 2005EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Nov 3, 2004CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 2, 2004CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 23, 2003CFITCASE FILE IN TICRS—
Jan 7, 2002DOCKASSIGNED TO EXAMINER—
May 23, 2001DOCKASSIGNED TO EXAMINER—
Apr 5, 2001DOCKASSIGNED TO EXAMINER—
Mar 30, 2000CNSLLETTER OF SUSPENSION MAILED—
Feb 23, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 23, 20001.BDSec. 1(B) CLAIM DELETED—
Feb 23, 200044EASEC. 44(E) CLAIM ADDED—
Aug 31, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 3, 1999DOCKASSIGNED TO EXAMINER—
Jul 26, 1999DOCKASSIGNED TO EXAMINER—
Jul 20, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance